Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The effects of the selective 5-HT1A receptor agonist gepirone (10 and 20 mg orally) on neuroendocrine function and temperature were assessed using a single-blind cross-over design in 12 healthy male volunteers. Gepirone significantly increased plasma levels of ACTH, beta-endorphin, cortisol, prolactin and growth hormone. Following gepirone there was a significant decrease in body temperature and moderate increases in subjective reports of light-headedness, nausea and drowsiness. Our results are consistent with studies in rodents suggesting that 5-HT1A receptor agonists increase ACTH and prolactin secretion and decrease body temperature. Further investigations are needed to determine if the neuroendocrine and temperature effects of gepirone in humans are mediated by 5-HT1A receptors.

Type

Journal article

Journal

Psychopharmacology (Berl)

Publication Date

1990

Volume

100

Pages

498 - 503

Keywords

Adrenocorticotropic Hormone, Adult, Body Temperature, Growth Hormone, Humans, Hydrocortisone, Male, Neurosecretory Systems, Prolactin, Pyrimidines, Radioimmunoassay, Receptors, Serotonin, Single-Blind Method, beta-Endorphin